惠升医药健康6个月持有期混合(010405)利润分配表
| |
2024-12-31 |
2024-06-30 |
2023-12-31 |
2023-06-30 |
| 收入 |
-98,813,978.06 |
-137,346,534.78 |
-46,331,324.33 |
-34,659,513.72 |
| 利息合计 |
787,527.86 |
373,273.59 |
1,006,501.35 |
577,575.82 |
| 其中：存款利息收入 |
787,527.86 |
373,273.59 |
1,006,501.35 |
577,575.82 |
| 债券利息收入 |
- |
- |
- |
- |
| 资产支持证券利息收入 |
- |
- |
- |
- |
| 买入返售金融资产收入 |
- |
- |
- |
- |
| 投资收益合计 |
-114,752,664.06 |
-74,414,058.70 |
-42,875,641.80 |
-19,095,822.25 |
| 其中：股票投资收益 |
-122,162,753.61 |
-78,631,491.17 |
-50,921,616.50 |
-24,988,172.99 |
| 基金投资收益 |
- |
- |
- |
- |
| 债券投资收益 |
- |
- |
-90,067.40 |
-90,067.40 |
| 资产支持证券投资收益 |
- |
- |
- |
- |
| 衍生工具收益 |
- |
- |
- |
- |
| 股利收益 |
7,410,089.55 |
4,217,432.47 |
8,136,042.10 |
5,982,418.14 |
| 基金分红收益收益 |
- |
- |
- |
- |
| 公允价值变动收益 |
15,150,713.23 |
-63,305,964.67 |
-4,485,843.88 |
-16,141,988.86 |
| 其他收入 |
444.91 |
215.00 |
23,660.00 |
721.57 |
| 费用 |
8,775,515.40 |
4,626,311.44 |
14,268,010.68 |
8,186,915.16 |
| 管理人报酬 |
7,629,373.78 |
4,027,097.31 |
12,727,775.60 |
7,362,812.93 |
| 基金托管费 |
953,671.62 |
503,387.13 |
1,355,527.62 |
736,281.31 |
| 销售服务费 |
- |
- |
- |
- |
| 交易费用 |
- |
- |
- |
- |
| 利息支出 |
- |
- |
- |
- |
| 其中：卖出回购金融资产支出 |
- |
- |
- |
- |
| 其他费用 |
192,470.00 |
95,827.00 |
184,707.46 |
87,820.92 |
| 利润总额 |
-107,589,493.46 |
-141,972,846.22 |
-60,599,335.01 |
-42,846,428.88 |
微信公众号
证券之星APP
基本资料
